Inventor · disambiguated record
Jeffrey B. Etter
Also filed as: ETTER JEFFREY · ETTER JEFFREY B
24 granted patents·19 pending applications·1,087 citations·filing 1992–2024
97Inventor score
Top patents by PatentIndex Score
43 records- 0197US5468606ADevices for detection of an analyte based upon light interferenceBIOSTAR INC·Filed 1992·Granted Nov 21, 1995·261 cites·47 claims
- 0296US5541057AMethods for detection of an analyteBIOSTAR INC·Filed 1993·Granted Jul 30, 1996·175 cites·30 claims
- 0396US5482830ADevices and methods for detection of an analyte based upon light interferenceBIOSTAR INC·Filed 1993·Granted Jan 9, 1996·167 cites·24 claims
- 0495US5639671AMethods for optimizing of an optical assay deviceBIOSTAR INC·Filed 1995·Granted Jun 17, 1997·171 cites·5 claims
- 0594US7125566B2Particulate drug-containing products and method of manufactureRXKINETIX INC·Filed 2003·Granted Oct 24, 2006·43 cites·31 claims
- 0692US10646503B2Isotopologues of 5-azacytidineCELGENE CORP·Filed 2019·Granted May 12, 2020·2 cites·1 claims
- 0792US5869272AMethods for detection of gram negative bacteriaBIOSTAR INC·Filed 1995·Granted Feb 9, 1999·106 cites·18 claims
- 0891US11571436B2Oral formulations of cytidine analogs and methods of use thereofCELGENE CORP·Filed 2021·Granted Feb 7, 2023·1 cites·22 claims
- 0991US8846628B2Oral formulations of cytidine analogs and methods of use thereofETTER JEFFREY B·Filed 2009·Granted Sep 30, 2014·20 cites·43 claims
- 1091US6649189B2Methods for use of delivery composition for expanding, activating, committing or mobilizing one or more pluripotent, self-renewing and committed stem cellsRXKINETIX INC·Filed 2001·Granted Nov 18, 2003·26 cites·79 claims
- 1190US2025082661A1Oral formulations of cytidine analogs and methods of use thereofCELGENE CORP·Filed 2024·Application pending·0 cites
- 1288US10463683B2Isotopologues of 5-azacytidineCELGENE CORP·Filed 2019·Granted Nov 5, 2019·3 cites·1 claims
- 1388US6685917B2Treatment of mucositisRXKINETIX INC·Filed 2001·Granted Feb 3, 2004·31 cites·23 claims
- 1487US12053482B2Oral formulations of cytidine analogs and methods of use thereofCELGENE CORP·Filed 2023·Granted Aug 6, 2024·0 cites·21 claims
- 1587US10220050B2Isotopologues of 5-azacytidineCELGENE CORP·Filed 2017·Granted Mar 5, 2019·3 cites·1 claims
- 1685US9987285B2High dosage strength tablets of rucaparibCLOVIS ONCOLOGY INC·Filed 2015·Granted Jun 5, 2018·2 cites·28 claims
- 1784US2023241086A1Oral formulations of cytidine analogs and methods of use thereofCELGENE CORP·Filed 2022·Application pending·0 cites
- 1883US6933112B1Device for mass transport assisted optical assaysTHERMO BIOSTAR INC·Filed 2000·Granted Aug 23, 2005·21 cites·33 claims
- 1982US10130636B2High dosage strength tablets of rucaparibCLOVIS ONCOLOGY INC·Filed 2018·Granted Nov 20, 2018·1 cites·11 claims
- 2081US6875441B2Composition for delivery of hematopoietic growth factorRXKINETIX INC·Filed 2001·Granted Apr 5, 2005·7 cites·34 claims
- 2181US6669960B2Particulate drug-containing products and method of manufactureRXKINETIX INC·Filed 2000·Granted Dec 30, 2003·9 cites·56 claims
- 2280US2022105118A1Oral formulations of cytidine analogs and methods of use thereofCELGENE CORP·Filed 2021·Application pending·0 cites
- 2376US2009232835A1Composition for delivery of hematopoietic growth factorROSENTHAL GARY J·Filed 2008·Application pending·0 cites
- 2475US9393255B2Pharmaceutical compositions of cytidine analogs and methods of use thereofTUTINO ANTHONY·Filed 2012·Granted Jul 19, 2016·3 cites·36 claims
- 2572US2020316099A1Isotopologues of 5-azacytidineCELGENE CORP·Filed 2020·Application pending·0 cites
- 2668US2015056280A1Isotopologues of 5-azacytidineCELGENE CORP·Filed 2014·Application pending·0 cites
- 2765US2005147683A1Composition for delivery of hematopoietic growth factorFiled 2005·Application pending·0 cites
- 2865US2005147682A1Composition for delivery of hematopoietic growth factorFiled 2005·Application pending·0 cites
- 2965US2005147684A1Composition for delivery of hematopoietic growth factorFiled 2005·Application pending·0 cites
- 3065US2007116776A1Particulate drug-containing products and method of manufactureETTER JEFFREY B·Filed 2006·Application pending·0 cites
- 3160US7153651B1Flow-through optical assay devices providing laminar flow of fluid samples, and methods of construction thereofINVERNESS MEDICAL BIOSTAR INC·Filed 1997·Granted Dec 26, 2006·21 cites·40 claims
- 3260US2015374732A1Oral formulations of cytidine analogs and methods of use thereofCELGENE CORP·Filed 2015·Application pending·0 cites
- 3358US2007071824A1Treatment of mucositis using N-acetylcysteineROSENTHAL GARY J·Filed 2006·Application pending·0 cites
- 3457US2007014860A1Treatment of esophagitisROSENTHAL GARY J·Filed 2006·Application pending·0 cites
- 3557US2007014861A1Treatment of proctitisROSENTHAL GARY J·Filed 2006·Application pending·0 cites
- 3655US2019099430A1High Dosage Strength Tablets of RucaparibCLOVIS ONCOLOGY INC·Filed 2018·Application pending·0 cites
- 3754US2004141949A1Treatment of mucositisFiled 2003·Application pending·0 cites
- 3853US6761909B1Particulate insulin-containing products and method of manufactureRXKINETIX INC·Filed 1999·Granted Jul 13, 2004·14 cites·55 claims
- 3952US2016250246A1Oral formulations of cytidine analogs and methods of use thereofCELGENE CORP·Filed 2016·Application pending·0 cites
- 4050US2015290228A1Oral formulations of cytidine analogs and methods of use thereofBACKSTROM JAY T·Filed 2015·Application pending·0 cites
- 4147US2008057086A1Colon-targeted oral formulations of cytidine analogsPHARMION CORP·Filed 2007·Application pending·0 cites
- 4243US7847120B2Compositions of allosteric hemoglobin modifiers and methods of making the sameUNIV VIRGINIA COMMONWEALTH·Filed 2005·Granted Dec 7, 2010·0 cites·40 claims
- 4337US8372798B2High-concentration protein formulations and method of manufactureENDO PHARMACEUTICALS COLORADO INC·Filed 2002·Granted Feb 12, 2013·0 cites·56 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →